265 related articles for article (PubMed ID: 10352275)
1. Characterization of scFv-Ig constructs generated from the anti-CD20 mAb 1F5 using linker peptides of varying lengths.
Shan D; Press OW; Tsu TT; Hayden MS; Ledbetter JA
J Immunol; 1999 Jun; 162(11):6589-95. PubMed ID: 10352275
[TBL] [Abstract][Full Text] [Related]
2. Human IgG1 Cgamma1 domain is crucial for the bioactivity of the engineered anti-CD20 antibodies.
Geng S; Feng J; Li Y; Kang X; Sun Y; Gu X; Huang Y; Chang H; Shen BF
Cell Mol Immunol; 2007 Apr; 4(2):121-5. PubMed ID: 17484806
[TBL] [Abstract][Full Text] [Related]
3. [Expression, structure prediction and functional analysis of murine single-chain fragment variable antibody against human cervical cancer].
Wang Y; Li X; Chen W
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jan; 26(1):16-21. PubMed ID: 16495168
[TBL] [Abstract][Full Text] [Related]
4. Binding activity difference of anti-CD20 scFv-Fc fusion protein derived from variable domain exchange.
Geng SS; Feng J; Li Y; Sun Y; Gu X; Huang Y; Wang Y; Kang X; Chang H; Shen B
Cell Mol Immunol; 2006 Dec; 3(6):439-43. PubMed ID: 17257497
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of scFv fragment reactivity with target antigens in binding assays following mixing with anti-tag monoclonal antibodies.
Wang X; Campoli M; Ko E; Luo W; Ferrone S
J Immunol Methods; 2004 Nov; 294(1-2):23-35. PubMed ID: 15604013
[TBL] [Abstract][Full Text] [Related]
6. Sheep red blood cells armed with anti-CD20 single-chain variable fragments (scFvs) fused to a glycosylphosphatidylinositol (GPI) anchor: a strategy to target CD20-positive tumor cells.
Hamdy N; Goustin AS; Desaulniers JP; Li M; Chow CS; Al-Katib A
J Immunol Methods; 2005 Feb; 297(1-2):109-24. PubMed ID: 15777935
[TBL] [Abstract][Full Text] [Related]
7. Tandemly repeated Fc domain augments binding avidities of antibodies for Fcgamma receptors, resulting in enhanced antibody-dependent cellular cytotoxicity.
Nagashima H; Tezuka T; Tsuchida W; Maeda H; Kohroki J; Masuho Y
Mol Immunol; 2008 May; 45(10):2752-63. PubMed ID: 18353438
[TBL] [Abstract][Full Text] [Related]
8. Production and characterization of a bacterial single-chain antibody fragment specific to B-cell-activating factor of the TNF family.
Cao P; Tang XM; Guan ZB; Diao ZY; Zhang SQ
Protein Expr Purif; 2005 Oct; 43(2):157-64. PubMed ID: 16023370
[TBL] [Abstract][Full Text] [Related]
9. Screening and evaluation of human single-chain fragment variable antibody against hepatitis B virus surface antigen.
Zhang JL; Gou JJ; Zhang ZY; Jing YX; Zhang L; Guo R; Yan P; Cheng NL; Niu B; Xie J
Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):237-41. PubMed ID: 16698583
[TBL] [Abstract][Full Text] [Related]
10. DNA binding by the VH domain of anti-Z-DNA antibody and its modulation by association of the VL domain.
Chen Y; Stollar BD
J Immunol; 1999 Apr; 162(8):4663-70. PubMed ID: 10202006
[TBL] [Abstract][Full Text] [Related]
11. Improved antigen binding by a CD20-specific single-chain antibody fragment with a mutation in CDRH1.
Adamson PJ; Millard DJ; Hohmann AW; Mavrangelos C; Macardle PJ; Pilkington G; Mulhern TD; Tedder TF; Zola H; Nicholson IC
Mol Immunol; 2006 Feb; 43(6):550-8. PubMed ID: 15936081
[TBL] [Abstract][Full Text] [Related]
12. [Construction, expression and functional characterization of single chain variable fragments (scFv) against human CD33 antigen].
Chen XJ; Wang Y; Qu H; Ge XS; Zuo YF; Liao XL
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Dec; 23(12):1147-9. PubMed ID: 18062889
[TBL] [Abstract][Full Text] [Related]
13. Construction and molecular characterization of mouse single-chain variable fragment antibodies against Burkholderia mallei and Burkholderia pseudomallei.
Kim HS; Tsai S; Zou N; Lo SC; Wear DJ; Izadjoo MJ
J Immunol Methods; 2011 Feb; 365(1-2):101-9. PubMed ID: 21172353
[TBL] [Abstract][Full Text] [Related]
14. Expression and purification of a single-chain variable fragment antibody derived from a polyol-responsive monoclonal antibody.
Lamberski JA; Thompson NE; Burgess RR
Protein Expr Purif; 2006 May; 47(1):82-92. PubMed ID: 16216525
[TBL] [Abstract][Full Text] [Related]
15. [Cloning of the variable region genes from hybridoma against bFGF and expression of single chain antibody fragments in E.coli HB2151].
Wang H; Chen D; Deng N; Xiang JJ; Jin YJ; Huang HL; Tang Y; Yang HY
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Dec; 23(12):1150-3. PubMed ID: 18062890
[TBL] [Abstract][Full Text] [Related]
16. [Construction and expression of single-chain Fv antibody against human VEGF].
Wang D; Yang X; Yuan Q
Zhonghua Yi Xue Za Zhi; 2000 Jul; 80(7):526-9. PubMed ID: 11798812
[TBL] [Abstract][Full Text] [Related]
17. Crystallization of single-chain Fv proteins.
Essig NZ; Wood JF; Howard AJ; Raag R; Whitlow M
J Mol Biol; 1993 Dec; 234(3):897-901. PubMed ID: 8254684
[TBL] [Abstract][Full Text] [Related]
18. [Construction and expression of anti-human AFP ScFv gene in BL-21 (DE3) E. coli].
Zhang P; Cai MY; Zhao ZR; Wei DP; Li G; Bi JH
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Jan; 36(1):20-3. PubMed ID: 15702771
[TBL] [Abstract][Full Text] [Related]
19. Monospecific bivalent scFv-SH: effects of linker length and location of an engineered cysteine on production, antigen binding activity and free SH accessibility.
Albrecht H; Denardo GL; Denardo SJ
J Immunol Methods; 2006 Mar; 310(1-2):100-16. PubMed ID: 16499921
[TBL] [Abstract][Full Text] [Related]
20. Production and characterization of an active single-chain variable fragment antibody recognizing CD25.
Muramatsu H; Yoshikawa K; Hayashi T; Takasu S; Kawada Y; Uchida K; Sato S; Takahashi T; Saga S; Ueda R
Cancer Lett; 2005 Jul; 225(2):225-36. PubMed ID: 15978327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]